The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122474693 12247469 3 F 20160312 20160914 20160407 20160922 EXP US-BIOGEN-2016BI00215795 BIOGEN 41.31 YR M Y 0.00000 20160922 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122474693 12247469 1 PS AVONEX INTERFERON BETA-1A 1 Intramuscular Y P41076 103628 30 UG SOLUTION FOR INJECTION IN PRE-FILLED PEN /wk

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122474693 12247469 1 Multiple sclerosis

Outcome of event

Event ID CASEID OUTC COD
122474693 12247469 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
122474693 12247469 Abdominal pain
122474693 12247469 Abdominal pain upper
122474693 12247469 Arthropathy
122474693 12247469 Bradykinesia
122474693 12247469 Chest discomfort
122474693 12247469 Chest pain
122474693 12247469 Dyspnoea
122474693 12247469 Gait disturbance
122474693 12247469 Gastric dilatation
122474693 12247469 Headache
122474693 12247469 Heart rate irregular
122474693 12247469 Influenza like illness
122474693 12247469 Injection site discharge
122474693 12247469 Injection site extravasation
122474693 12247469 Injection site haemorrhage
122474693 12247469 Injection site rash
122474693 12247469 Malaise
122474693 12247469 Multiple sclerosis
122474693 12247469 Nephrolithiasis
122474693 12247469 Pulmonary oedema
122474693 12247469 Speech disorder
122474693 12247469 Visual impairment

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122474693 12247469 1 20140602 20160312 0